Skip to main content
. 2021 Oct 15;12:752397. doi: 10.3389/fimmu.2021.752397

Figure 1.

Figure 1

Covaxin induces elevated plasma levels of Type 1, Type 17 and other pro-inflammatory cytokines. (A) The plasma levels of Type 1 and Type 17 cytokines in Covaxin vaccinated individuals at baseline [before vaccination, M0] (n = 44) and month 1 following first dose [M1] (n = 44), month 2 following first dose [M2] (n = 44) and month 3 following first dose [M3] (n = 44). (B) The plasma levels of other pro-inflammatory cytokines in Covaxin vaccinated individuals at baseline [before vaccination, M0] (n = 44) and month 1 following first dose [M1] (n = 44), month 2 following first dose [M2] (n = 44) and month 3 following first dose [M3] (n = 44). The data are represented as Box and whiskers scatter plots with each circle representing a single individual, p values were calculated using the Kruskal-Wallis test t-test multiple comparisons.